{"product_id":"sermorelin","title":"Sermorelin","description":"\u003cp dir=\"ltr\"\u003e\u003cspan\u003eA synthetic 29-amino-acid analog of GHRH studied for its effects on pituitary growth hormone secretion. One of the most established GH research peptides.\u003c\/span\u003e\u003c\/p\u003e\n\u003ch3 dir=\"ltr\"\u003e\u003cspan\u003eWhat Is Sermorelin?\u003c\/span\u003e\u003c\/h3\u003e\n\u003cp dir=\"ltr\"\u003e\u003cspan\u003eSermorelin is a synthetic peptide consisting of the first 29 amino acids of the 44-amino-acid human growth hormone-releasing hormone (GHRH). It was one of the first GHRH analogs approved for clinical use (Geref) and remains one of the most well-characterized compounds in GH research. Sermorelin stimulates pituitary GH production through a natural, pulsatile pattern.\u003c\/span\u003e\u003c\/p\u003e\n\u003ch3 dir=\"ltr\"\u003e\u003cspan\u003eHistory\u003c\/span\u003e\u003c\/h3\u003e\n\u003cp dir=\"ltr\"\u003e\u003cspan\u003eSermorelin was developed following the isolation and characterization of human GHRH in 1982 by researchers at the Salk Institute. The 29-amino-acid fragment was found to retain the full biological activity of the 44-amino-acid parent molecule. Sermorelin received regulatory approval in 1997 under the brand name Geref for diagnostic use. Though Geref was later discontinued due to manufacturing issues (not safety concerns), sermorelin remains one of the most extensively studied and well-characterized GHRH analogs in the research literature.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp dir=\"ltr\"\u003e \u003c\/p\u003e","brand":"Protocol Aminos","offers":[{"title":"5MG","offer_id":44808005845037,"sku":null,"price":55.0,"currency_code":"COP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0744\/2232\/1197\/files\/Sermorelin.png?v=1775606028","url":"https:\/\/protocolaminos.com\/products\/sermorelin","provider":"Protocol Aminos","version":"1.0","type":"link"}